½ÃÀ庸°í¼­
»óǰÄÚµå
1402727

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¿¹Ãø(-2030³â) - Áö¿ªº° ºÐ¼® : Á¦Ç°, ¼ö¹ý, ÃÖÁ¾ »ç¿ëÀÚ

Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Forecast to 2030 - Regional Analysis - Product (Dental Bone Graft Substitute and Dental Barrier Membrane), Procedures, and End User (Hospitals, Dental Clinics, and Others)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 106 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº 2022³â 9,942¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 2¾ï 768¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2022³âºÎÅÍ 2030³â±îÁö CAGRÀº 9.6%·Î Àü¸ÁµË´Ï´Ù.

CAD ¹× CAM ±â¼úÀ» ÅëÇÑ Ä¡°ú ÀÇ·á µðÁöÅÐÈ­°¡ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÑ´Ù.

ÄÄÇ»ÅÍ Áö¿ø ¼³°è(CAD) ¹× ÄÄÇ»ÅÍ Áö¿ø Á¦Á¶(CAM) ¼ÒÇÁÆ®¿þ¾î´Â Ä¡°úÀǻ簡 º¹ÀâÇÑ Ä¡·á¸¦ ´õ ºü¸¥ ¼Óµµ·Î, º¸´Ù Á¤È®Çϰí, ÀûÀº ³ë·ÂÀ¸·Î ¼öÇàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. CAD ¹× CAM ½Ã½ºÅÛÀÇ ÀåÁ¡À¸·Î´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ Á¶ÀÛ, µðÁöÅÐ Àλó, ÇÑ ¹øÀÇ ¹æ¹®À¸·Î Ä¡·á, ȯÀÚÀÇ ¾ÈÀü¼º Çâ»ó ¹× ¿À·¡ Áö¼ÓµÇ´Â ¼öº¹¹° µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ CAD ¹× CAMÀ» ÅëÇÕÇÑ µðÁöÅÐ Ä¡°ú´Â Ä¡°ú Áø·á¼ÒÀÇ »ý»ê¼º ¹× ¼öÀͼºÀ» ³ôÀÔ´Ï´Ù. °ü·Ã ±â¼úÀÇ Áøº¸¸¦ ÅëÇÑ Ä¡°úÀÇ µðÁöÅÐÈ­´Â Àǻ簡 Ä¡·á ¼ö¸® ´Ü°è¿¡ ÇÊ¿äÇÑ ½Ã°£À» ´ëÆø ´ÜÃàÇÔÀ¸·Î½á ȯÀÚÀÇ Ä¡·á¸¦ °³¼±ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ CAD ¼ÒÇÁÆ®¿þ¾î´Â Ä¡°ú±â±¸ÀÇ µðÁöÅÐ ¼³°è¸¦ ¿ëÀÌÇÏ°Ô Çϸç CAM ¼ÒÇÁÆ®¿þ¾î´Â ¼³°èµÈ Á¦Ç°ÀÇ Á¦Á¶¸¦ Áö¿øÇÕ´Ï´Ù. ÃֽŠÁ¦Á¶ °øÁ¤ÀÇ Á¤È®¼º°ú ½Å·Ú¼º, 3D ½ºÄ³´×Àº ´õ¿í ½Å·ÚÇÒ ¼ö ÀÖ´Â Ä¡°ú¿ëǰÀÇ Á¦Á¶·Î À̾îÁö°í ÀÖ½À´Ï´Ù. CAD ¹× CAM ±â¼úÀº ÀÌÁ¾ ÀÌ½ÄÆí, µ¿Á¾ ÀÌ½ÄÆí ¹× µ¿Á¾°¡¼Ò¼º ÀÌ½ÄÆíÀÇ ¸ÂÃãÇü ºí·Ï ÀÌ½ÄÆíÀ» ¹Ð¸µÇÏ´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ¶ÇÇÑ º¹ÀâÇÑ À¶±â º¸°­ ÀýÂ÷¸¦ À§ÇÑ µ¿Á¾ »À ºí·ÏÀÇ ¸ÂÃãÇü Á¦Á¶¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ¿Í °°ÀÌ Ä¡°úÀÇ·á¿¡¼­ CAD ¹× CAM ±â¼úÀÇ ÀÌ¿ëÀº ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­ ÁÖ¸ñÇÒ ¸¸ÇÑ µ¿ÇâÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå °³¿ä

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Áß±¹, ÀϺ», Àεµ, È£ÁÖ, Çѱ¹ ¹× ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ±¸ºÐµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº Ä¡°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ÁöÃâ Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡, ±¸°­ À§»ý ÀÇ½Ä ¹× ±â¼ú Áøº¸ ±ÞÁõ, ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­ Ä¡°ú Áø·á¼Ò °³Ã´À» À§ÇÑ ½ÃÀå ÁøÃâ ±â¾÷ÀÇ ÁÖ¸ñÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾ç Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼öÀÍ ¹× ¿¹Ãø(±Ý¾×)(-2030³â)

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼¼ºÐÈ­

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Á¦Ç°, ÀýÂ÷, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ºÐÇҵ˴ϴÙ.

Á¦Ç°¿¡ µû¶ó ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°°ú Ä¡°ú¿ë ¹è¸®¾î ¸âºê·¹ÀÎÀ¸·Î À̺е˴ϴÙ. Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ºÎ¹®Àº 2022³â ¾Æ½Ã¾ÆÅÂÆò¾ç Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­ ´õ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Ä¡·á¿¡ µû¶ó ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº °¡À̵å Çϰñ Àç»ý(GBR) Ä¡·á, °¡À̵å ÇÏ Á¶Á÷ Àç»ý(GTR) Ä¡·á, »çÀ̳ʽº ¸®ÇÁÆ® ¹× ¸®Áö ½ºÇø´ Ä¡·á, Ä¡Á¶°ñ À¶±â º¸Á¸(ARP), ºí·Ï ÀÌ½Ä Ã³Ä¡, Ä¡ÁÖ Àç»ý óġ, ¼ÒÄÏ ÀúÀå µîÀ¸·Î ºÐÇҵ˴ϴÙ. 2022³â ¾Æ½Ã¾ÆÅÂÆò¾ç Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­´Â »çÀ̳ʽº ¸®ÇÁÆ®¿Í ¸®Áö ºÐÇÒ ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚ¸¦ ±â¹ÝÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº º´¿ø, Ä¡°ú Ŭ¸®´Ð µîÀ¸·Î ±¸ºÐµË´Ï´Ù. Ä¡°ú Ŭ¸®´Ð ºÎ¹®Àº 2022³â ¾Æ½Ã¾ÆÅÂÆò¾ç Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Áß±¹, ÀϺ», Àεµ, È£ÁÖ, Çѱ¹ ¹× ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ±¸ºÐµË´Ï´Ù. 2022³â ¾Æ½Ã¾ÆÅÂÆò¾ç Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Áß±¹ÀÌ µ¶Á¡ÇÏ¿´½À´Ï´Ù.

Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regensity Biosciences Inc, Neoss UK &Ireland Ltd¡¢Institut Straumann AG´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå »óȲ

  • ¼­·Ð
  • PEST ºÐ¼®
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ PEST ºÐ¼®

Á¦5Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ÁÖ¿ä »ê¾÷¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Ä¡ÁÖº´ ¹× ±¸°­¾ÏÀÇ ºÎ´ãÁõ
    • ½ÃÀå ÁøÃâ±â¾÷ÀÇ Àü·«Àû °³Ã´
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç°°ú óġÀÇ °íºñ¿ë ¹× Ä¡°ú °ËÁø Áö¿¬
  • ½ÃÀå ±âȸ
    • Ä¡°úÀÇ·á¿¡ À־ÀÇ ±â¼ú °³¹ß
  • ÇâÈÄÀÇ µ¿Çâ
    • CAD ¹× CAM ±â¼ú¿¡ ÀÇÇÑ Ä¡°ú ÀÇ·áÀÇ µðÁöÅÐÈ­
  • ¿µÇ⠺м®

Á¦6Àå Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¸ÅÃâ(2022-2030³â)

Á¦7Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : Á¦Ç°º° ¼öÀÍ ¹× ¿¹Ãø(-2030³â)

  • ¼­·Ð
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : Á¦Ç°º° ¸ÅÃâ Á¡À¯À²(%)(2022³â ¹× 2030³â)
  • Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°
  • Ä¡°ú¿ë ¹è¸®¾î ¸âºê·¹ÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ¼ö¹ýº° ¼öÀÍ ¹× ¿¹Ãø(-2030³â)

  • ¼­·Ð
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ¼ö¹ýº° ¸ÅÃâ Á¡À¯À²(%)(2022³â ¹× 2030³â)
  • °¡À̵å Çϰñ Àç»ý ó¸®(GBR)
  • À¯µµ Á¶Á÷ Àç»ý ó¸®(GTR)
  • »çÀ̳ʽº ¸®ÇÁÆ®¹ý°ú ¸®Áö ½ºÇø´¹ý
  • Ä¡Á¶°ñ À¶±âÀÇ º¸Á¸(ARP)
  • ºí·Ï ±×·¡ÇÁÆ®¹ý
  • Ä¡ÁÖ Àç»ý óġ
  • ¼ÒÄÏ ÇÁ¸®ÀÚº£À̼Ç
  • ±âŸ

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº° ¼öÀÍ ¹× ¿¹Ãø(-2030³â)

  • ¼­·Ð
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº° ¸ÅÃâ Á¡À¯À²(%)(2022³â ¹× 2030³â)
  • º´¿ø
  • Ä¡°ú Áø·á¼Ò
  • ±âŸ

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ±¹°¡º° ºÐ¼®

  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¾÷°è Á¤¼¼

  • ¼­·Ð
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼ºÀå Àü·«
  • À¯±âÀû Àü°³
  • ¹«±âÀû Àü°³

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Geistlich Pharma AG
  • Medtronic Plc
  • Dentsply Sirona Inc
  • ZimVie Inc
  • Regenity Biosciences Inc
  • Neoss UK & Ireland Ltd
  • Institut Straumann AG

Á¦13Àå ºÎ·Ï

AJY 24.01.18

The Asia Pacific dental bone graft substitute and barrier membrane market is expected to grow from US$ 99.42 million in 2022 to US$ 207.68 million by 2030. It is estimated to grow at a CAGR of 9.6% from 2022 to 2030.

Digitization of Dentistry with CAD/CAM Technology Fuel Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market

Computer-aided design (CAD) and computer-aided manufacturing (CAM) software help dentists perform complex procedures at an accelerated pace, with greater accuracy, and lesser efforts. The benefits of CAD/CAM systems include user-friendly operations, digital impressions, single-visit treatments, improved patient safety, and long-lasting restorations. Moreover, digital dentistry with the integration of CAD/CAM enhances the productivity and profitability of a dental practice. The digitalization of dentistry with advancements in relevant technologies has enabled physicians to improve patient care by significantly reducing the time required for the restorative phase of treatment. CAD software also facilitates the digital designing of dental appliances, and CAM software aids in the manufacturing of the designed products. The accuracy and dependability of modern manufacturing processes, and 3D scanning have further led to more reliable manufacturing of dental objects. The CAD/CAM technology can be used for the milling of customized block grafts of xenogeneic, allogeneic, and alloplastic origins. The technology also enables the customized production of allogeneic bone blocks for complex ridge augmentation procedures. Thus, the use of CAD/CAM technology in dentistry is emerging as a notable trend in the Asia Pacific dental bone graft substitute and barrier membrane market .

Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Overview

The Asia Pacific Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is expected to be the fastest-growing region during the forecast period. The market in Asia Pacific is expected to grow at a faster pace owing to factors such as high prevalence of dental problems, increased healthcare expenditure, and rise in the aging population. Moreover, increase in government initiatives, surge in oral health awareness and technological advancements, and an increasing focus of market players in emerging economies for developing dental practices are expected to boost the growth of the Asia Pacific Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market during the forecast period.

Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Segmentation

The Asia Pacific dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user and country.

Based on product, the Asia Pacific dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.

Based on procedures, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.

Based on end user, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.

Based on country, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.

Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd and Institut Straumann AG in are some the leading companies operating in the Asia Pacific dental bone graft substitute and barrier membrane market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific dental bone graft substitute and barrier membrane market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific dental bone graft substitute and barrier membrane market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Burden of Periodontal Diseases and Oral Cancer
    • 5.1.2 Strategic Developments by Market Players
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Products & Procedures and Delays in Dental Check-ups
  • 5.3 Market Opportunities
    • 5.3.1 Technological Developments in Dentistry
  • 5.4 Future Trends
    • 5.4.1 Digitization of Dentistry with CAD/CAM Technology
  • 5.5 Impact Analysis:

6. Dental Bone Graft Substitute and Barrier Membrane Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Dental Bone Graft Substitute
    • 7.3.1 Overview
    • 7.3.2 Dental Bone Graft Substitute: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Allograft
      • 7.3.3.1 Overview
      • 7.3.3.2 Allograft: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Xenograft
      • 7.3.4.1 Overview
      • 7.3.4.2 Xenograft: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Synthetic Bone Graft
      • 7.3.5.1 Overview
      • 7.3.5.2 Synthetic Bone Graft: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Autografts
      • 7.3.6.1 Overview
      • 7.3.6.2 Autografts: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.7 Alloplasts
      • 7.3.7.1 Overview
      • 7.3.7.2 Alloplasts: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.8 Demineralized Bone Matrix (DBM)- Allograft
      • 7.3.8.1 Overview
      • 7.3.8.2 Demineralized Bone Matrix (DBM)- Allograft: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.9 Others
      • 7.3.9.1 Overview
      • 7.3.9.2 Others: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Dental Barrier Membrane
    • 7.4.1 Overview
    • 7.4.2 Dental Barrier Membrane: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 Resorbable Membrane
      • 7.4.3.1 Overview
      • 7.4.3.2 Resorbable Membrane: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Non-Resorbable Membrane
      • 7.4.4.1 Overview
      • 7.4.4.2 Non-Resorbable Membrane: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Procedures

  • 8.1 Overview
  • 8.2 Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by Procedures 2022 & 2030 (%)
  • 8.3 Guided Bone Regeneration Procedures (GBR)
    • 8.3.1 Overview
    • 8.3.2 Guided Bone Regeneration Procedures (GBR): Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Guided Tissue Regeneration Procedures (GTR)
    • 8.4.1 Overview
    • 8.4.2 Guided Tissue Regeneration Procedures (GTR): Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Sinus-lift Procedures and Ridge-split Procedures
    • 8.5.1 Overview
    • 8.5.2 Sinus-lift Procedures and Ridge-split Procedures: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Alveolar Ridge Preservation (ARP)
    • 8.6.1 Overview
    • 8.6.2 Alveolar Ridge Preservation (ARP): Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Block-graft Procedures
    • 8.7.1 Overview
    • 8.7.2 Block-graft Procedures: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Periodontal Regeneration Procedures
    • 8.8.1 Overview
    • 8.8.2 Periodontal Regeneration Procedures: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Socket Preservation
    • 8.9.1 Overview
    • 8.9.2 Socket Preservation: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Dental Clinics
    • 9.4.1 Overview
    • 9.4.2 Dental Clinics: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Country Analysis

  • 10.1 Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, Revenue And Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market by Country
      • 10.1.1.2 China
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 China Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 China Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.2.3.1 China Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.2.3.2 China Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.2.4 China Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.2.5 China Dental Bone Graft Substitute and Barrier Membrane Market, by End User
      • 10.1.1.3 Japan
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Japan Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Japan Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.3.3.1 Japan Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.3.3.2 Japan Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.3.4 Japan Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.3.5 Japan Dental Bone Graft Substitute and Barrier Membrane Market, by End User
      • 10.1.1.4 India
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 India Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 India Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.4.3.1 India Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.4.3.2 India Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.4.4 India Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.4.5 India Dental Bone Graft Substitute and Barrier Membrane Market, by End User
      • 10.1.1.5 Australia
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Australia Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.5.3.1 Australia Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.5.3.2 Australia Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.5.4 Australia Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.5.5 Australia Dental Bone Graft Substitute and Barrier Membrane Market, by End User
      • 10.1.1.6 South Korea
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 South Korea Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 South Korea Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.6.3.1 South Korea Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.6.3.2 South Korea Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.6.4 South Korea Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.6.5 South Korea Dental Bone Graft Substitute and Barrier Membrane Market, by End User
      • 10.1.1.7 Rest of Asia Pacific
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Rest of Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.7.3 Rest of Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.7.3.1 Rest of Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.7.3.2 Rest of Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.7.4 Rest of Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.7.5 Rest of Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, by End User

11. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, Key Company Profiles

  • 12.1 Geistlich Pharma AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Dentsply Sirona Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 ZimVie Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Regenity Biosciences Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Neoss UK & Ireland Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Institut Straumann AG
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦